Lemon Stephen J, Crannage Andrew J
Department of Pharmacy, Cleveland Clinic, Ohio, USA.
Adv Emerg Nurs J. 2011 Jul-Sep;33(3):212-23; quiz 224-5. doi: 10.1097/TME.0b013e31822638ae.
Anticoagulation therapies are 1 of the most commonly encountered therapeutic areas by health care professionals each day. One of the most important adverse effects of anticoagulation therapy is life-threatening hemorrhage, and it may result in visits to the emergency department. Some of the common reversal agents include Vitamin K, protamine sulfate, desmopressin, recombinant Factor VIIa, and prothrombin complex concentrates. Each of these agents has the potential to reverse specific anticoagulation therapies, but each agent has a unique administration procedure and monitoring parameters. However, these agents are not without risk of adverse effects. Knowledge of unique aspects of each reversal agent and the anticoagulation therapy must be considered when selecting or recommending pharmacologic anticoagulation reversal therapy. The intent of this review is to discuss the relevant management issues associated with anticoagulant reversal in the emergency department.
抗凝治疗是医护人员每天最常遇到的治疗领域之一。抗凝治疗最重要的不良反应之一是危及生命的出血,这可能导致患者前往急诊科就诊。一些常见的逆转剂包括维生素K、硫酸鱼精蛋白、去氨加压素、重组凝血因子VIIa和凝血酶原复合物浓缩剂。这些药物中的每一种都有可能逆转特定的抗凝治疗,但每种药物都有独特的给药程序和监测参数。然而,这些药物并非没有不良反应风险。在选择或推荐药物性抗凝逆转治疗时,必须考虑每种逆转剂和抗凝治疗的独特方面。本综述的目的是讨论急诊科与抗凝逆转相关的管理问题。